Dimethylamine

Dimethylamine

SCHEMBL4125348

C#CC1(COc2ccc3c(CCC4CCN(C(=O)O)CC4)noc3c2C)CC1.CNC

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 12/20 0.38
BCHE P06276 3/20 0.36
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL4115787 0.92 GPR119 (0.37) ACHE
Dimethylamine SCHEMBL4120402 0.91 ACHE (0.38) ACHEBCHEMEN1KMT2A
Dimethylamine SCHEMBL4120519 0.89 ACHE (0.38) ACHEBCHE
SCHEMBL4112262 0.87 ACHE (0.38) ACHEBCHE
Dimethylamine SCHEMBL4120781 0.87 ACHE (0.41) ACHEBCHE
SCHEMBL4125345 0.87 ACHE (0.38) ACHEBCHE
Dimethylamine SCHEMBL4127429 0.85 ACHE (0.42) ACHEBCHE
Dimethylamine SCHEMBL4120298 0.84 ACHE (0.42) ACHEBCHE
Dimethylamine SCHEMBL4131039 0.83 ACHE (0.41) ACHEBCHE
Dimethylamine SCHEMBL4124810 0.83 GPR119 (0.37) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885BCHE 2215/4885MEN1 1361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.